Literature DB >> 6339265

Allophenic mice produced from embryos aggregated with antibody.

J Palmer, M J Dewey.   

Abstract

One difficulty in the production of allophenic mice by aggregation of preimplantation embryos is that they frequently roll apart before the bonds between the blastomeres have had time to form. One solution to the problem, described here, is to pretreat one of the embryos with rabbit anti-mouse serum just prior to pushing them together. Blastocyst formation is unhampered by antibody treatment, and numerous allophenic mice have already been produced with this new procedure.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6339265     DOI： 10.1007/bf01958897

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  7 in total

1.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

2.  Stable alterations at the cell membrane of Chinese hamster ovary cells resistant to the cytotoxicity of phytohemagglutinin.

Authors:  P Stanley; V Caillibot; L Siminovitch
Journal:  Somatic Cell Genet       Date:  1975-01

Review 3.  Gene control of mammalian differentiation.

Authors:  B Mintz
Journal:  Annu Rev Genet       Date:  1974       Impact factor: 16.830

4.  Phytohemagglutinin-mediated blastomere aggregation and development of allophenic mice.

Authors:  B Mintz; J D Gearhart; A O Guymont
Journal:  Dev Biol       Date:  1973-03       Impact factor: 3.582

5.  Ability of outside cells from preimplantation mouse embryos to form inner cell mass derivatives.

Authors:  J Rossant; K M Vijh
Journal:  Dev Biol       Date:  1980-05       Impact factor: 3.582

6.  Improved complementation in the cytotoxic test.

Authors:  E A Boyse; L Hubbard; E Stockert; M E Lamm
Journal:  Transplantation       Date:  1970-11       Impact factor: 4.939

7.  Experimental Study of the Developing Mammalian Egg: Removal of the Zona Pellucida.

Authors:  B Mintz
Journal:  Science       Date:  1962-11-02       Impact factor: 47.728
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.